About

Ten years of tracking where tech meets bio

WTMB Group is an independent research and media company covering AI and technology in drug discovery and pharma R&D.

Our story

BioPharmaTrend started in 2016 as a blog on AI in drug discovery, written by two chemistry PhDs from Kyiv, Andrii Buvailo and Oleg Kucheriavyi. It grew into a publication cited by Deloitte, RAND Corporation, the European Parliament and Nature Reviews Drug Discovery.

In 2026 we brought BioPharmaTrend, the Where Tech Meets Bio newsletter and The Biotech Edge together as WTMB Research & Media, based in Spain.

What we believe

Evidence over announcements

We ask what a company has actually shown, not what its press release claims.

Science literacy first

Our editors are scientists. We read the papers, not just the funding news.

Clear separation of editorial and sponsored work

Sponsored content is always labelled. Sponsors never buy coverage in our independent analysis.

Team

Who we are

AB

Andrii Buvailo, PhD

Co-founder and Editor-in-Chief

PhD in physical chemistry. Spent eight years at Enamine as Director of E‑commerce and Marketing. Writes on AI in drug discovery, platform companies and techbio investment. Published in Forbes.

Check out Andrii's website →
OK

Oleg Kuchriavyi

Co-Founder and CTO

PhD in physical chemistry.

Cited by
Deloitte RAND Corporation The World Bank European Parliament Nature Reviews Drug Discovery MIT Sloan Ernst & Young Imperial College London Forbes C&EN GEN Foley & Lardner National Research Foundation, Singapore Elsevier Federal Ministry of Economic Affairs of Germany IFPMA

Work with us

Download media kit →